Sensorion Announces Agenda For R&D Day Showcasing Gene Therapy For Inner Ear Disease
Thursday April 6, 2023, at 8am EDT, 2pm CEST Regulatory News: Sensorion, (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies
Source: finanznachrichten.de